Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline versus doxycycline + zinc sulfate for acne vulgaris
IRCT20100102002954N17Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of doxycycline and zinc in acne vulgaris (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoint: Acne healing speed. Started Oct 2019; status: completed.
02
Drugs
doxycyclinezinc
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20100102002954N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100102002954N17.